Literature DB >> 27075461

Assessment of vascular function in systemic onset juvenile idiopathic arthritis.

Betul Sozeri1, Basak Yildiz Atikan2, Kadriye Ozdemir3, Sevgi Mir3.   

Abstract

An increased incidence of cardiovascular disease has been found in rheumatic disorders. Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children. Prolonged immunological inflammatory process leads these patients to an early onset of atherosclerosis. We aimed to assess the presence of early vascular dysfunction in patients with systemic onset juvenile idiopathic arthritis (sJIA) and investigate the role of therapy sJIA in vascular health. Thirty-three patients (22 males, 11 females) diagnosed with sJIA according to the International League of Associations for Rheumatology criteria were compared to 72 age- and sex-matched controls. None of the participants was overweight, obese, or had a history of hypertension, dyslipidemia, diabetes mellitus, or cardiovascular disease. Arterial stiffness (As) was evaluated by measurement of carotid-femoral pulse wave velocity (PWV) and augmentation index (AIx) with a Vicorder. The mean age of patients in this study was 9.96 ± 3.71 years (range 4-16 years) and the mean age of controls was 10.9 ± 3.52 years (range 4-19 years). These two groups were well matched for age, sex, and BMI. The mean age of patients at the onset of disease was 7.06 ± 3.9 years (range 3-15 years). The mean duration of disease and active disease was 79 ± 45 months (range 6-162 months) and 58 ± 49 months (range 1-101 months), respectively. The highest levels of PWV and AIx were found in the patient group. Seven patients had had macrophage activation syndrome at presentation. In these patients, vascular changes were higher than other patients (6.30 ± 0.42 m/s vs 5.17 ± 0.55 m/s, p = 0.01, respectively). The corticosteroid therapy was found associated with higher PWV, (p < 0.05), while there was no difference between vascular parameters and use of non-steroid therapies (methotrexate (MTX), anti-TNF alfa agents). We also find statistically significant correlation between PWV and disease duration (p = 0.003, r = 0.45). Vascular function is impaired in patients with sJIA at a very young age. Vascular dysfunction may be partly attributed to the effects of disease-related characteristics (inflammation, disease activity, and medications).

Entities:  

Keywords:  Atherosclerosis; Systemic juvenile idiopathic arthritis; Vascular function

Mesh:

Substances:

Year:  2016        PMID: 27075461     DOI: 10.1007/s10067-016-3254-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  29 in total

1.  Lifetime risk factors and arterial pulse wave velocity in adulthood: the cardiovascular risk in young Finns study.

Authors:  Heikki Aatola; Nina Hutri-Kähönen; Markus Juonala; Jorma S A Viikari; Janne Hulkkonen; Tomi Laitinen; Leena Taittonen; Terho Lehtimäki; Olli T Raitakari; Mika Kähönen
Journal:  Hypertension       Date:  2010-01-18       Impact factor: 10.190

2.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

3.  Circulating levels of soluble E-selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis.

Authors:  F De Benedetti; M Vivarelli; P Pignatti; M Oliveri; M Massa; A Pistorio; A Martini
Journal:  J Rheumatol       Date:  2000-09       Impact factor: 4.666

Review 4.  Systemic juvenile idiopathic arthritis.

Authors:  Alberto Martini
Journal:  Autoimmun Rev       Date:  2012-08-02       Impact factor: 9.754

Review 5.  Update on the pathogenesis and treatment of systemic idiopathic arthritis.

Authors:  Keith A Sikora; Alexei A Grom
Journal:  Curr Opin Pediatr       Date:  2011-12       Impact factor: 2.856

Review 6.  Chronic inflammatory diseases and cardiovascular risk: a systematic review.

Authors:  Idan Roifman; Paul L Beck; Todd J Anderson; Mark J Eisenberg; Jacques Genest
Journal:  Can J Cardiol       Date:  2011 Mar-Apr       Impact factor: 5.223

Review 7.  [Nailfold videocapillaroscopy - a useful tool for screening patients with juvenile idiopathic arthritis at the risk of development of premature atherosclerosis].

Authors:  Anna Górska; Lidia Rutkowska-Sak; Elzbieta Musiej-Nowakowska; Sławomir Chlabicz; Stanisław Górski
Journal:  Postepy Hig Med Dosw (Online)       Date:  2010-06-15       Impact factor: 0.270

8.  Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study).

Authors:  Matteo Cesari; Brenda W J H Penninx; Anne B Newman; Stephen B Kritchevsky; Barbara J Nicklas; Kim Sutton-Tyrrell; Russell P Tracy; Susan M Rubin; Tamara B Harris; Marco Pahor
Journal:  Am J Cardiol       Date:  2003-09-01       Impact factor: 2.778

9.  Assessments of arterial stiffness and endothelial function using pulse wave analysis.

Authors:  Lee Stoner; Joanna M Young; Simon Fryer
Journal:  Int J Vasc Med       Date:  2012-05-14

Review 10.  Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.

Authors:  Ernest Choy; Kandeepan Ganeshalingam; Anne Grete Semb; Zoltán Szekanecz; Michael Nurmohamed
Journal:  Rheumatology (Oxford)       Date:  2014-06-06       Impact factor: 7.580

View more
  3 in total

1.  Evaluation of development of subclinical atherosclerosis in children with uveitis.

Authors:  Seçil Conkar; Suzan Güven Yılmaz; İlker Özgür Koska; Afig Berdeli; Sevgi Mir
Journal:  Clin Rheumatol       Date:  2017-07-10       Impact factor: 2.980

Review 2.  Cardiovascular disease in patients with autoinflammatory syndromes.

Authors:  Rainer Hintenberger; Agnes Falkinger; Kathrin Danninger; Herwig Pieringer
Journal:  Rheumatol Int       Date:  2017-11-01       Impact factor: 2.631

Review 3.  Inflammation as A Precursor of Atherothrombosis, Diabetes and Early Vascular Aging.

Authors:  Elena Barbu; Mihaela-Roxana Popescu; Andreea-Catarina Popescu; Serban-Mihai Balanescu
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.